Preimplantation Genetic Diagnosis Market Size, Trends, Shares, and Forecast - 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Preimplantation Genetic Diagnosis Market covers analysis By Type (Chromosomal Abnormalities, Aneuploidy, X-linked Diseases, Single Gene Disorders, HLA Typing, Gender selection, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Dec 2025
  • Report Code : TIPRE00005167
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Sep 2025

MARKET INTRODUCTION

Preimplantation Genetic Diagnosis is a process that is used prior to implantation for helping in identifying of genetic defects within an embryo. This serves to prevent certain genetic diseases or disorders from being passed on to the child.

MARKET DYNAMICS

The Preimplantation Genetic Diagnosis market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of genetic, hereditary and chromosomal diseases, rising rates in birth defects, increasing awareness among the population regarding prevention of genetic diseases, increasing awareness about reproductive health, high demand of in vitro fertilization treatments and advancements in the PGF availing diagnosis of disease such as cancer. Nevertheless, ethical issues related to sex determination and strict regulations is expected to restrict the market growth during the forecast period.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Preimplantation Genetic Diagnosis Market: Strategic Insights

preimplantation-genetic-diagnosis-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

The "Global Preimplantation Genetic Diagnosis Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Preimplantation Genetic Diagnosis market with detailed market segmentation by Test and geography. The global Preimplantation Genetic Diagnosis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Preimplantation Genetic Diagnosis market players and offers key trends and opportunities in the market.

Preimplantation Genetic Diagnosis Market Regional Insights

The regional trends and factors influencing the Preimplantation Genetic Diagnosis Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Preimplantation Genetic Diagnosis Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Preimplantation Genetic Diagnosis Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031)XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Chromosomal ABillionormalities
  • Aneuploidy
  • X-linked Diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Quest Diagnostics Inc.
  • Genesis Genetics Ltd
  • Reproductive Genetics Innovations LLC
  • Laboratory Corporation of America Holdings
  • Natera, Inc
  • PerkinElmer, Inc
  • Reprogenetics, LLC.
  • Genea Limited
  • F. Hoffmann-La Roche AG

Preimplantation Genetic Diagnosis Market Players Density: Understanding Its Impact on Business Dynamics

The Preimplantation Genetic Diagnosis Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


preimplantation-genetic-diagnosis-market-cagr

  • Get the Preimplantation Genetic Diagnosis Market top key players overview

MARKET SEGMENTATION

The global Preimplantation Genetic Diagnosis market is segmented on the basis of Type. Based on type the market is segmented into Chromosomal Abnormalities, Aneuploidy, X-linked Diseases, Single Gene Disorders, HLA Typing, Gender selection, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Preimplantation Genetic Diagnosis market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Preimplantation Genetic Diagnosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Preimplantation Genetic Diagnosis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Preimplantation Genetic Diagnosis market in these regions.

MARKET PLAYERS

The reports cover key developments in the Preimplantation Genetic Diagnosis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Preimplantation Genetic Diagnosis market are anticipated to lucrative growth opportunities in the future with the rising demand for Preimplantation Genetic Diagnosis market in the global market. Below mentioned is the list of few companies engaged in the Preimplantation Genetic Diagnosis market.

The report also includes the profiles of Preimplantation Genetic Diagnosis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Quest Diagnostics Inc.
  •  Genesis Genetics Ltd
  •  Reproductive Genetics Innovations LLC
  •  Laboratory Corporation of America Holdings
  •  Natera, Inc
  •  PerkinElmer, Inc
  •  Reprogenetics, LLC.
  •  Genea Limited
  •  F. Hoffmann-La Roche AG
  •  Illumina, Inc

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo